powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1518226034
Thomas Weart
M.D.
Hematology-Oncology
North Chesterfield,
VA
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
Healthparse Signals
Monitor this provider for changes — dated NPI change events
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
1,921
Unique beneficiaries
—
Total services
57,048
Distinct HCPCS
44
Medicare payment
$1.5M
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 239 Hematology-Oncology providers in VA — top quintile (cohort median 37,558).
PRESCRIBING · PART D · 2024
Total Rx claims
876
Beneficiaries
—
Total drug cost
$1.8M
Distinct drugs
28
Brand share
34.8%
Top prescribed drugs
Apixaban
110 claims
Oxycodone Hcl
85 claims
Letrozole
74 claims
Prochlorperazine Maleate
58 claims
Hydroxyurea
51 claims
QUALITY · MIPS · 2024
Final MIPS score
85.4
Quality
69.4
Cost
0.0
Improvement activities
40.0
Promoting interop.
93.0
Payment adjustment
0.44%
Individual
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$1K
Payment records
69
By payment type
Food and Beverage
$1K
Top paying entities
Food and Beverage
$1K
